Achalasia: Botox, dilatation or laparoscopic surgery in 2006

Neurogastroenterology and Motility

Volumn 18, Issue 9, 2006, Pages 799-804

  Pehlivanov, N ^a   Pasricha, P J ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

EDITORIAL; ENDOSCOPIC SURGERY; ESOPHAGUS ACHALASIA; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; MYOTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; DILATATION; ESOPHAGEAL ACHALASIA; HUMANS; LAPAROSCOPY; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33746886604     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00802.x     Document Type: Editorial

References (41)

1. Vaezi MF, Richter JE. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 1999; 94: 3406-12.
2. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005; 100: 1404-14.
3. Pehlivanov N, Pasricha PJ. Management of achalasia and diffuse esophageal spasm: Strategies for treatment, pneumatic dilatation, and botulinum toxin. Nat Clin Pract Gastroenterol Hepatol 2006; in press.
4. Kadakia SC, Wong RK. Pneumatic balloon dilation for esophageal achalasia. Gastrointest Endosc Clin N Am 2001; 11: 325-46, vii.
5. Abir F, Modlin I, Kidd M, Bell R. Surgical treatment of achalasia: current status and controversies. Dig Surg 2004; 21: 165-76.
6. O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE. The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci 2002; 47: 1516-25.
7. Panaccione R, Gregor JC, Reynolds RP, Preiksaitis HG. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest Endosc 1999; 50: 492-8.
8. Zaninotto G, Annese V, Costantini M et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg 2004; 239: 364-70.
9. Zaninotto G, Vergadoro V, Annese V et al. Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial. Surg Endosc 2004; 18: 691-5.
10. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5.
11. D'Onofrio V, Miletto P, Leandro G, Iaquinto G. Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 2002; 34: 105-10.
12. Kolbasnik J, Waterfall WE, Fachnie B, Chen Y, Tougas G. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol 1999; 94: 3434-9.
13. Zarate N, Mearin F, Baldovino F, Armengol JR, Malagelada JR. Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 2002; 14: 285-90.
14. Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998; 27: 21-35.
15. Spiess AE, Kahrilas PJ. Treating achalasia: from whale-bone to laparoscope. JAMA 1998; 280: 638-42.
16. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-8.
17. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-33.
18. Torbey CF, Achkar E, Rice TW, Baker M, Richter JE. Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol 1999; 28: 125-30.
19. Karamanolis G, Sgouros S, Karatzias G et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005; 100: 270-4.
20. Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004; 99: 2304-10.
21. Malthaner RA, Tood TR, Miller L, Pearson FG. Long-term results in surgically managed esophageal achalasia. Ann Thorac Surg 1994; 58: 1343-6; discussion 1346-7.
22. Ellis FH Jr, Watkins E Jr, Gibb SP, Heatley GJ. Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg 1992; 6: 86-9; discussion 90.
23. Khajanchee YS, Kanneganti S, Leatherwood AE, Hansen PD, Swanstrom LL. Laparoscopic Heller myotomy with Toupet fundoplication: outcomes predictors in 121 consecutive patients. Arch Surg 2005; 140: 827-33; discussion 833-4.
24. Bonatti H, Hinder RA, Klocker J et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg 2006; 190: 874-8.
25. Gockel I, Junginger T, Eckardt VF. Effects of pneumatic dilation and myotomy on esophageal function and morphology in patients with achalasia. Am Surg 2005; 71: 128-31.
26. Annese V, Bassotti G, Coccia G et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000; 46: 597-600.
27. Neubrand M, Scheurlen C, Schepke M, Sauerbruch T. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002; 34: 519-23.
28. Csendes A, Braghetto I, Henriquez A, Cortes C. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 1989; 30: 299-304.
29. Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004; 2: 389-94.
30. Omura N, Kashiwagi H, Ishibashi Y et al. Laparoscopic Heller myotomy and Dor fundoplication for the treatment of achalasia: assessment in relation to morphologic type. Surg Endosc 2006; 20(2): 210-3.
31. Richardson WS, Willis GW, Smith JW. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003; 17: 696-8.
32. Raftopoulos Y, Landreneau RJ, Hayetian F et al. Factors affecting quality of life after minimally invasive Heller myotomy for achalasia. J Gastrointest Surg 2004; 8: 233-9.
33. Bonavina L, Incarbone R, Antoniazzi L, Reitano M, Peracchia A. Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia. Ital J Gastroenterol Hepatol 1999; 31: 827-30.
34. Rakita S, Bloomston M, Villadolid D, Thometz D, Zervos E, Rosemurgy A. Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome. J Gastrointest Surg 2005; 9: 159-64.
35. Woltman TA, Pellegrini CA, Oelschlager BK. Achalasia. Surg Clin North Am 2005; 85: 483-93.
36. Horgan S, Pellegrini CA. Botulinum toxin injections for achalasia symptoms. Am J Gastroenterol 1999; 94: 300-1.
37. Portale G, Costantini M, Rizzetto C et al. Long-term outcome of Laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment. J Gastrointest Surg 2005; 9: 1332-9.
38. Nair LA, Reynolds JC, Parkman HP et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome. Dig Dis Sci 1993; 38: 1893-904.
39. Katz PO, Gilbert J, Castell DO. Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci 1998; 43: 1973-7.
40. Kostic SV, Rice TW, Baker ME et al.. Timed barium esophagogram: A simple physiologic assessment for achalasia. J Thorac Cardiovasc Surg 2000; 120: 935-43.
41. Barrett NR. Achalasia of the Cardia: Reflections Upon a Clinical Study of over 100 Cases. Br Med J 1964; 5391: 1135-40.